GLABF
Price
$0.37
Change
+$0.01 (+2.78%)
Updated
Aug 20 closing price
Capitalization
27.12M
SLXN
Price
$7.74
Change
+$0.48 (+6.61%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
5.66M
Interact to see
Advertisement

GLABF vs SLXN

Header iconGLABF vs SLXN Comparison
Open Charts GLABF vs SLXNBanner chart's image
GEMINA LABORATORIES
Price$0.37
Change+$0.01 (+2.78%)
Volume$200
Capitalization27.12M
Silexion Therapeutics
Price$7.74
Change+$0.48 (+6.61%)
Volume$300
Capitalization5.66M
GLABF vs SLXN Comparison Chart in %
Loading...
GLABF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLABF vs. SLXN commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLABF is a Hold and SLXN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (GLABF: $0.37 vs. SLXN: $7.26)
Brand notoriety: GLABF and SLXN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLABF: 2% vs. SLXN: 19%
Market capitalization -- GLABF: $27.12M vs. SLXN: $5.66M
GLABF [@Biotechnology] is valued at $27.12M. SLXN’s [@Biotechnology] market capitalization is $5.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLABF’s FA Score shows that 0 FA rating(s) are green whileSLXN’s FA Score has 0 green FA rating(s).

  • GLABF’s FA Score: 0 green, 5 red.
  • SLXN’s FA Score: 0 green, 5 red.
According to our system of comparison, SLXN is a better buy in the long-term than GLABF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLABF’s TA Score shows that 4 TA indicator(s) are bullish while SLXN’s TA Score has 5 bullish TA indicator(s).

  • GLABF’s TA Score: 4 bullish, 4 bearish.
  • SLXN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SLXN is a better buy in the short-term than GLABF.

Price Growth

GLABF (@Biotechnology) experienced а 0.00% price change this week, while SLXN (@Biotechnology) price change was +6.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.10%. For the same industry, the average monthly price growth was +14.72%, and the average quarterly price growth was +30.35%.

Industries' Descriptions

@Biotechnology (+2.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLABF($27.1M) has a higher market cap than SLXN($5.66M). GLABF YTD gains are higher at: -32.530 vs. SLXN (-75.920). GLABF has higher annual earnings (EBITDA): -3.73M vs. SLXN (-17.81M). SLXN has more cash in the bank: 3.47M vs. GLABF (15K). GLABF has less debt than SLXN: GLABF (244K) vs SLXN (3.7M). GLABF has higher revenues than SLXN: GLABF (10.9K) vs SLXN (0).
GLABFSLXNGLABF / SLXN
Capitalization27.1M5.66M479%
EBITDA-3.73M-17.81M21%
Gain YTD-32.530-75.92043%
P/E RatioN/AN/A-
Revenue10.9K0-
Total Cash15K3.47M0%
Total Debt244K3.7M7%
TECHNICAL ANALYSIS
Technical Analysis
GLABFSLXN
RSI
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
64%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
52%
Bullish Trend 2 days ago
35%
Momentum
ODDS (%)
Bearish Trend 2 days ago
55%
Bearish Trend 2 days ago
22%
MACD
ODDS (%)
Bearish Trend 2 days ago
63%
Bullish Trend 2 days ago
28%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
40%
Bullish Trend 2 days ago
27%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 2 days ago
52%
Advances
ODDS (%)
Bullish Trend 23 days ago
83%
Bullish Trend 2 days ago
53%
Declines
ODDS (%)
N/A
Bearish Trend 8 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
50%
Bullish Trend 4 days ago
38%
Aroon
ODDS (%)
Bearish Trend 2 days ago
67%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
GLABF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UGRO0.430.03
+6.99%
urban-gro
BALY10.090.20
+2.02%
Bally's Corporation
FBNC55.300.43
+0.78%
First Bancorp
GLPI47.950.20
+0.42%
Gaming and Leisure Properties
GOCO5.30-0.11
-2.03%
GoHealth

GLABF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLABF has been loosely correlated with ELVAF. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if GLABF jumps, then ELVAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLABF
1D Price
Change %
GLABF100%
N/A
ELVAF - GLABF
36%
Loosely correlated
N/A
TNFA - GLABF
29%
Poorly correlated
+15.53%
IDRSF - GLABF
23%
Poorly correlated
N/A
VYGR - GLABF
22%
Poorly correlated
N/A
ENTO - GLABF
8%
Poorly correlated
+0.53%
More

SLXN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLXN has been loosely correlated with IMA. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SLXN jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLXN
1D Price
Change %
SLXN100%
+0.83%
IMA - SLXN
63%
Loosely correlated
+0.07%
CELC - SLXN
50%
Loosely correlated
+1.01%
MRSN - SLXN
43%
Loosely correlated
-0.26%
CHRS - SLXN
26%
Poorly correlated
+0.88%
QSI - SLXN
25%
Poorly correlated
-0.85%
More